Colby Wood has over 25 years of investment experience in both public and private companies with expertise in healthcare and medical devices. He has been actively involved as an investor, asset gatherer and business development executive for early-stage companies in both the financial services and medical technology sectors.
CAREER HIGHLIGHTS
- Portfolio Manager and Equity Research Analyst with Oechsle International Advisors in London and Boston
- Consultant at Freeman & Company
- Interim President at GI Windows
- Early-stage investor in Dermasensor, Shockwave, Procept, Auris, Next Health, Neptune, Reflexion, Cephea, Empirical Spine and GI Windows
BOARD AND ADVISORY SEATS
- Director at Vitestro
- Director at Ziteo
- Former Director at Procept BioRobotics, Inc. (NASDAQ: PRCT)
- Former Director at GI Windows
EDUCATION / ACCOLADES
- B.A. from University of Delaware
- MBA in Finance and Entrepreneurship from F.W. Olin Graduate School of Business at Babson College
